It is one of the more counterintuitive findings in men's health: the same compounds that build dramatic muscle mass and project an image of peak virility frequently leave their users unable to achieve an erection. The relationship between anabolic steroids and erectile dysfunction is well documented in andrology and sexual-medicine research, and it runs deeper than most users anticipate when they begin a cycle. Anabolic-androgenic steroids (AAS)—synthetic derivatives of testosterone used non-medically to enhance physique and performance—reliably suppress the body's own hormonal machinery. The downstream consequences for erectile function can be significant, and in a meaningful subset of men they outlast the steroid use itself by months or years.
How Anabolic Steroids Suppress Natural Testosterone
Normal testosterone production is governed by a feedback loop known as the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases gonadotropin-releasing hormone, which signals the pituitary to secrete luteinizing hormone and follicle-stimulating hormone, which in turn instruct the testes to manufacture testosterone and sperm. This system is self-regulating: when the brain detects high circulating androgen levels, it dials production down.
Anabolic steroids flood the body with exogenous androgens far in excess of anything it produces naturally. The brain interprets this surplus as a signal to shut off its own output. Luteinizing hormone and follicle-stimulating hormone fall, the testes stop producing endogenous testosterone, and over time they often shrink—the testicular atrophy familiar to long-term users. As long as the external supply continues, circulating androgen levels may stay high. But the moment a cycle ends, users are left with suppressed natural production and a hormonal vacuum that can take a long time to refill. This post-cycle window is when erectile difficulties and collapsed libido most commonly surface.
Why Steroid Use Disrupts Erections
It may seem paradoxical that high androgen exposure would impair erectile function, since testosterone is essential for healthy male sexuality. The explanation lies in the difference between supraphysiologic androgen levels and a balanced endocrine environment. Erections depend on far more than testosterone alone—they require intact nerve signaling, healthy blood vessels, adequate nitric oxide production, and a favorable hormonal milieu, including a workable balance between testosterone and estrogen.
Several mechanisms converge during and after steroid use. Many AAS aromatize into estrogen, and the resulting hormonal imbalance can blunt sexual response and contribute to gynecomastia. Some compounds suppress libido directly at the level of the central nervous system. And once a cycle ends, the steep drop into hypogonadism—clinically low testosterone—removes the hormonal support that erectile tissue and sexual desire rely on. Layered on top of this, certain steroids adversely affect cardiovascular health and endothelial function, the vascular lining responsible for the nitric oxide signaling that initiates an erection. The result is a condition that is simultaneously hormonal, vascular, and psychological in origin.
What the Studies Report
The clinical literature paints a consistent picture. In a case-control study published in PLOS One, researchers examined men with a history of long-term anabolic steroid use and found that former users exhibited markedly higher rates of hypogonadal symptoms years after they had stopped. Erectile dysfunction was reported in roughly 27 percent of former AAS users—substantially more than in non-using controls—and many continued to show measurably depressed testosterone levels long after cessation [1].
A review in Fertility and Sterility characterized anabolic steroid–induced hypogonadism as an increasingly recognized clinical entity, noting that erectile dysfunction and diminished libido rank among the most common complaints in this population, particularly during the post-cycle period when endogenous testosterone is at its lowest [2]. A more recent sexual-medicine analysis in the International Journal of Impotence Research reinforced that sexual dysfunction—including erectile difficulties, reduced desire, and ejaculatory problems—is a frequent and under-discussed consequence of non-medical androgen use [3].
The persistence of these effects is a recurring theme. A scoping review on recovery from anabolic steroid–induced hypogonadism documented that hormonal, physical, and psychological normalization can be slow and incomplete, with some men not regaining baseline function for many months [4]. Research focused specifically on younger men using exogenous testosterone and related substances has raised parallel concerns about fertility and long-term endocrine health, underscoring that the risks are not confined to older or longtime users [5].
Recovery, Reversibility, and the Post-Cycle Reality
The encouraging part of the evidence is that anabolic steroid–induced hypogonadism is often, though not always, reversible. Once exogenous androgens clear the system, the HPG axis can gradually restart—the hypothalamus and pituitary resume signaling, and the testes slowly return toward normal production. For many men, sexual function improves as natural testosterone recovers.
The complicating part is that recovery is unpredictable. The likelihood and speed of normalization appear to depend on the dose, duration, and specific compounds used, as well as the individual's age and baseline endocrine health. Men who used high doses for years face longer and less certain recoveries than those with brief, modest exposure. In some cases, hypogonadal symptoms—including erectile dysfunction—persist long enough that clinical evaluation and supervised intervention become appropriate. This is why physicians who treat this population emphasize proper assessment rather than self-managed "post-cycle therapy" regimens sourced online, which are frequently unvalidated and occasionally harmful. A medical workup can distinguish a slow but recovering axis from one that needs support, and can identify the contribution of vascular or psychological factors that may respond to targeted treatment.
The Broader Lesson for Erectile Health
Anabolic steroid–associated erectile dysfunction is a vivid illustration of a principle that runs through all of sexual medicine: an erection is a barometer of integrated physiological health, not a simple function of how much androgen is in the blood. Hormonal balance, vascular integrity, nitric oxide availability, and nervous-system signaling all have to cooperate. Disrupting any one of these systems—even in pursuit of a more muscular physique—can compromise the whole.
For men currently weighing performance-enhancing drugs, the evidence offers a sober counterweight to the marketing. For those already experiencing post-cycle erectile difficulties, the message is more hopeful: the condition is often treatable, especially with a clear diagnosis and an evidence-based plan. Erectile dysfunction can also be an early signal of underlying cardiovascular or endocrine issues, which makes a proper evaluation valuable beyond the immediate sexual symptom. Readers exploring the wider science can review related articles on low testosterone and vascular health on the blog.
Conclusion
The link between anabolic steroids and erectile dysfunction is neither rare nor mysterious. By overwhelming the body's natural hormonal feedback system, AAS suppress endogenous testosterone production and create a hormonal environment that frequently undermines erectile function—most acutely in the post-cycle period, and sometimes for years afterward. Clinical studies suggest that while recovery is possible for many men, it is highly variable and warrants medical attention when symptoms persist. The most reliable path forward combines an honest assessment of risk with proper diagnosis and treatment rather than guesswork.
If you're exploring clinically-formulated options, OnyxMD offers physician-supervised treatment plans starting with a free online assessment at questionnaire.getonyxmd.com. You can also learn more about prescription on-demand options like Mach 1.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
Rasmussen JJ, Selmer C, Østergren PB, et al. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study. PLOS One. 2016;11(8):e0161208. doi:10.1371/journal.pone.0161208
Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid–induced hypogonadism: diagnosis and treatment. Fertility and Sterility. 2014;101(5):1271-1279. doi:10.1016/j.fertnstert.2014.02.002
Health consequences of anabolic steroids: a sexual-medicine perspective. International Journal of Impotence Research. 2026. doi:10.1038/s41443-026-01272-1
Physical, psychological and biochemical recovery from anabolic steroid–induced hypogonadism: a scoping review. Therapeutic Advances in Endocrinology and Metabolism. 2023;14. PMC10620455
Non-medical use of exogenous testosterone and anabolic–androgenic substances in young men: health, psychological, and fertility consequences. Frontiers in Endocrinology. 2026;17:1781416. doi:10.3389/fendo.2026.1781416
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.